Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SPROSpero Therapeutics, Inc.

Nasdaq · CIK 0001701108
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts305

Identity from submissions API

NameSpero Therapeutics, Inc.
CIK0001701108
TickersSPRO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857-242-1600
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Spero Therapeutics, LLC (2017-03-21T04:00:00.000Z → 2017-03-21T04:00:00.000Z)
Business address
675 MASSACHUSETTS AVENUE
14TH FLOOR
CAMBRIDGE
MA
02139
MA
Mailing address
675 MASSACHUSETTS AVENUE
14TH FLOOR
CAMBRIDGE
MA
02139
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

521 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 8-K 8-K 2.02 0001193125-26-458637 001-38266 261547800 34 606274 1 1
2026-11-12 10-Q 10-Q 0001193125-26-458593 001-38266 261547669 34 15011498 1 1
2026-11-10 4 4 0001193125-26-455873 5201
2026-11-10 4 4 0001193125-26-455869 5474
2026-11-10 3 3 0001193125-26-455868 14468
2026-11-10 8-K 8-K 5.02 0001193125-26-455789 001-38266 261541760 34 142758 1 1
2026-10-28 S-8 S-8 0001193125-26-436376 333-299682 261496648 33 273651 1 1
2026-10-27 8-K 8-K 5.02 0001193125-26-434452 001-38266 261491490 34 137670 1 1
2026-09-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002937 333-298641 261372604 33 1870
2026-08-28 8-K 8-K 1.01,8.01,9.01 0001193125-26-374788 001-38266 261341606 34 148971 1 1
2026-08-28 S-3 S-3 0001193125-26-374702 333-298641 261341317 33 1739140 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001193125-26-346855 001-38266 261267538 34 210346 1 1
2026-08-12 10-Q 10-Q 0001193125-26-346795 001-38266 261267369 34 14569020 1 1
2026-08-06 4 4 0001807743-26-000007 7478
2026-08-06 3 3 0001807743-26-000005 3336
2026-07-14 8-K 8-K 1.01,2.03,7.01,8.01,9.01 0001193125-26-302473 001-38266 261172501 34 3531667 1 1
2026-06-25 4 4 0001193125-26-283245 7273
2026-06-25 4 4 0001193125-26-283238 7302
2026-06-25 4 4 0001193125-26-283230 7250
2026-06-25 4 4 0001193125-26-283226 7277
2026-06-25 4 4 0001193125-26-283209 7278
2026-06-25 4 4 0001193125-26-283202 7250
2026-06-25 4 4 0001193125-26-283198 7278
2026-06-25 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-26-283033 001-38266 261122935 34 174955 1 1
2026-06-23 S-8 S-8 0001193125-26-279429 333-296972 261111063 33 311844 1 1
2026-06-22 8-K 8-K 7.01,8.01,9.01 0001193125-26-277506 001-38266 261107005 34 183412 1 1
2026-05-13 10-Q 10-Q 0001193125-26-221591 001-38266 26973212 34 8628002 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001193125-26-221567 001-38266 26973105 34 194544 1 1
2026-05-06 4 4 0001193125-26-209884 5225
2026-04-27 ARS ARS 0001193125-26-182287 001-38266 26901683 34 904330
2026-04-27 DEFA14A DEFA14A 0001193125-26-182256 001-38266 26901630 34 213427
2026-04-27 DEF 14A DEF 14A 0001193125-26-182201 001-38266 26901478 34 3101424 1 1
2026-04-13 PRE 14A PRE 14A 0001193125-26-153115 001-38266 26858610 34 3248510 1 1
2026-03-26 8-K 8-K 2.02,9.01 0001193125-26-126244 001-38266 26798331 34 215188 1 1
2026-03-26 10-K 10-K 0001193125-26-126192 001-38266 26798077 34 13650416 1 1
2026-02-09 4 4 0001193125-26-043336 6538
2026-02-09 4 4 0001193125-26-043315 5058
2026-02-05 4 4 0001193125-26-038441 12102
2026-02-04 4 4 0001193125-26-038184 9237
2026-01-30 8-K 8-K 5.02,8.01 0001193125-26-032004 001-38266 26584278 34 137976 1 1
2025-12-19 8-K 8-K 8.01,9.01 0001193125-25-325821 001-38266 251585130 34 143153 1 1
2025-11-13 8-K 8-K 2.02,7.01,9.01 0001193125-25-280518 001-38266 251479793 34 9066447 1 1
2025-11-13 10-Q 10-Q 0001193125-25-280174 001-38266 251478543 34 10002064 1 1
2025-11-12 4 4 0001193125-25-278370 5067
2025-09-03 4 4 0000950170-25-112661 5177
2025-09-03 4 4 0000950170-25-112659 5034
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-109211 005-90168 251222254 34 15168
2025-08-12 S-8 S-8 0001193125-25-179082 333-289544 251207836 33 203813 1 1
2025-08-12 10-Q 10-Q 0000950170-25-107388 001-38266 251207248 34 9782578 1 1
2025-08-12 8-K 8-K 2.02,7.01,9.01 0001193125-25-178970 001-38266 251206979 34 2786146 1 1
2025-06-18 8-K 8-K 5.02,5.07 0001193125-25-142807 001-38266 251057831 34 152593 1 1
2025-06-16 4 4 0000950170-25-087021 5082
2025-06-16 4 4 0000950170-25-087020 4853
2025-06-16 4 4 0000950170-25-087017 4828
2025-06-16 4 4 0000950170-25-087015 4818
2025-06-16 4 4 0000950170-25-087013 4859
2025-06-16 4 4 0000950170-25-087010 4812
2025-06-16 4 4 0000950170-25-087009 4859
2025-06-16 4 4 0000950170-25-087008 4880
2025-05-28 8-K 8-K 7.01,8.01,9.01 0001193125-25-128680 001-38266 25991141 34 177147 1 1
2025-05-13 8-K 8-K 2.02,9.01 0001193125-25-118882 001-38266 25940981 34 197641 1 1
2025-05-13 10-Q 10-Q 0000950170-25-070380 001-38266 25940324 34 8862179 1 1
2025-05-06 4 4 0000950170-25-064821 5007
2025-04-28 ARS ARS 0001193125-25-100819 001-38266 25881480 34 12994184
2025-04-28 DEFA14A DEFA14A 0001193125-25-100624 001-38266 25880818 34 431970
2025-04-28 DEF 14A DEF 14A 0001193125-25-100544 001-38266 25880578 34 2456262 1 1
2025-04-28 8-K 8-K 5.02,9.01 0001193125-25-100433 001-38266 25880155 34 174168 1 1
2025-03-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001999371-25-003391 005-90168 25786871 34 29755
2025-03-27 8-K 8-K 2.02,9.01 0001193125-25-065633 001-38266 25780582 34 226381 1 1
2025-03-27 10-K 10-K 0000950170-25-046125 001-38266 25779816 34 15563481 1 1
2025-02-28 8-K 8-K 3.01 0001193125-25-042785 001-38266 25692054 34 148109 1 1
2025-02-05 4 4 0000950170-25-014866 10157
2025-02-05 4 4 0000950170-25-014859 8361
2025-02-05 4 4 0000950170-25-014850 10143
2025-02-05 4 4 0000950170-25-014849 6872
2025-01-10 8-K 8-K 2.02,5.02,7.01,8.01,9.01 0001193125-25-004063 001-38266 25520344 34 4932594 1 1
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258822 005-90168 241464647 34 121722
2024-11-14 8-K 8-K 2.02,9.01 0001193125-24-258540 001-38266 241461943 34 212794 1 1
2024-11-14 10-Q 10-Q 0000950170-24-127016 001-38266 241461625 34 8456053 1 1
2024-11-12 4 4 0000950170-24-125339 6298
2024-10-29 8-K 8-K 2.02,2.05,7.01,8.01,9.01 0001193125-24-246627 001-38266 241406525 34 3655536 1 1
2024-09-10 8-K 8-K 7.01,9.01 0001193125-24-216310 001-38266 241288721 34 13591448 1 1
2024-08-29 4 4 0000950170-24-102000 4953
2024-08-29 4 4 0000950170-24-101998 4961
2024-08-29 4 4 0000950170-24-101993 4909
2024-08-06 4 4 0000950170-24-092170 6314
2024-08-05 S-8 S-8 0001193125-24-193960 333-281245 241175164 33 76551
2024-08-05 10-Q 10-Q 0000950170-24-090782 001-38266 241175011 34 7659920 1 1
2024-08-05 8-K 8-K 2.02,7.01,9.01 0001193125-24-193913 001-38266 241174893 34 13054206 1 1
2024-06-03 8-K 8-K 5.02,5.07,9.01 0001193125-24-153034 001-38266 241013798 34 299200 1 1
2024-05-30 4 4 0000950170-24-066659 4862
2024-05-30 4 4 0000950170-24-066652 4841
2024-05-30 4 4 0000950170-24-066625 5092
2024-05-30 4 4 0000950170-24-066622 4837
2024-05-30 4 4 0000950170-24-066624 4892
2024-05-30 4 4 0000950170-24-066619 4824
2024-05-30 4 4 0000950170-24-066617 4869
2024-05-30 4 4 0000950170-24-066616 4869
2024-05-15 8-K 8-K 2.02,9.01 0001193125-24-139364 001-38266 24950464 34 203597 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060400 001-38266 24950194 34 7214618 1 1
2024-04-16 ARS ARS 0001193125-24-097774 001-38266 24848062 34 1199284
2024-04-16 DEFA14A DEFA14A 0001193125-24-097763 001-38266 24848016 34 147716
2024-04-16 DEF 14A DEF 14A 0001193125-24-097749 001-38266 24847948 34 2182936 1 1
2024-03-29 8-K 8-K 8.01 0001193125-24-082060 001-38266 24804185 34 143867 1 1
2024-03-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-03-22 16:00:00 9999999995-24-000719 333-277998 24776780 33 1876
2024-03-20 CORRESP filename1.htm 0001193125-24-072581 7475
2024-03-20 UPLOAD filename1.pdf 0000000000-24-003036 333-277998 40468
2024-03-15 S-3 S-3 0001193125-24-069196 333-277998 24755366 33 1225645
2024-03-15 S-8 S-8 0001193125-24-069149 333-277984 24755032 33 76671
2024-03-13 10-K 10-K 0000950170-24-030767 001-38266 24746020 34 14737812 1 1
2024-03-13 8-K 8-K 2.02,9.01 0001193125-24-066825 001-38266 24745973 34 231183 1 1
2024-02-14 SC 13G SC 13G 0001193125-24-036304 005-90168 24638872 34 128145
2024-02-09 8-K 8-K 5.02 0001193125-24-029913 001-38266 24614701 34 148344 1 1
2024-02-05 4 4 0000950170-24-011501 7140
2024-02-05 4 4 0000950170-24-011496 5550
2024-02-05 4 4 0000950170-24-011494 7062
2024-02-05 4 4 0000950170-24-011491 7065
2024-02-05 4 4 0000950170-24-011490 4998
2024-02-05 4 4 0000950170-24-011487 8764
2024-02-05 144 xsl144X01/primary_doc.xml 0001950047-24-000665 001-38266 24596487 33 5705
2024-01-08 8-K 8-K 7.01,9.01 0001193125-24-003807 001-38266 24518185 34 3958999 1 1
2024-01-05 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-24-002894 001-38266 24514482 34 3996530 1 1
2024-01-04 4 4 0000950170-24-001971 5742
2024-01-02 8-K 8-K 7.01,8.01,9.01 0001193125-24-000249 001-38266 24500344 34 179800 1 1
2023-11-15 4 4 0000950170-23-064189 4914
2023-11-15 3 3 0000950170-23-064185 17310
2023-11-13 S-8 S-8 0001193125-23-276143 333-275515 231399701 33 163403
2023-11-13 S-8 S-8 0001193125-23-276127 333-275514 231399621 33 76140
2023-11-13 8-K 8-K 2.02,9.01 0001193125-23-276030 001-38266 231398854 34 226070 1 1
2023-11-13 10-Q 10-Q 0000950170-23-062897 001-38266 231398469 34 10272460 1 1
2023-11-01 8-K 8-K 5.02,8.01,9.01 0001193125-23-267758 001-38266 231366648 34 179383 1 1
2023-10-16 8-K/A 8-K/A 5.03,5.07,9.01 0001193125-23-256865 001-38266 231327360 34 166505 1 1
2023-10-10 4 4 0000950170-23-052721 4784
2023-10-10 4 4 0000950170-23-052716 4608
2023-10-10 4 4 0000950170-23-052715 4787
2023-10-10 4 4 0000950170-23-052710 4781
2023-10-10 4 4 0000950170-23-052703 4811
2023-10-10 4 4 0000950170-23-052701 4756
2023-10-10 4 4 0000950170-23-052693 4759
2023-10-10 4 4 0000950170-23-052692 5007
2023-10-10 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-23-253136 001-38266 231315823 34 325923 1 1
2023-09-15 4 4 0000950170-23-048440 5772
2023-09-01 ARS ARS 0001193125-23-227646 001-38266 231232634 34 13837554
2023-09-01 DEF 14A DEF 14A 0001193125-23-227642 001-38266 231232596 34 2227489
2023-08-30 4 4 0000950170-23-045450 4919
2023-08-30 4 4 0000950170-23-045448 4837
2023-08-30 4 4 0000950170-23-045442 5061
2023-08-30 4 4 0000950170-23-045441 6512
2023-08-29 144 xsl144X01/primary_doc.xml 0001950047-23-003493 001-38266 231222124 33 5460
2023-08-22 PRE 14A PRE 14A 0001193125-23-218127 001-38266 231194603 34 2123580
2023-08-10 S-8 S-8 0001193125-23-209085 333-273880 231159937 33 261686
2023-08-10 8-K 8-K 2.02,9.01 0001193125-23-209064 001-38266 231159752 34 214275 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041314 001-38266 231159394 34 11108611 1 1
2023-08-03 4 4 0000950170-23-037973 4885
2023-07-31 8-K 8-K 7.01,8.01,9.01 0001193125-23-198589 001-38266 231125136 34 180240 1 1
2023-07-24 3 3 0000950170-23-034095 13508
2023-06-14 4 4 0000950170-23-027860 5422
2023-06-14 8-K 8-K 5.02,8.01,9.01 0001193125-23-166543 001-38266 231013044 34 196770 1 1
2023-05-11 8-K 8-K 2.02,9.01 0001193125-23-142023 001-38266 23911139 34 202611 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021187 001-38266 23910805 34 8770332 1 1
2023-03-30 S-8 S-8 0001193125-23-085694 333-271000 23781344 33 76056
2023-03-30 8-K 8-K 2.02,9.01 0001193125-23-085566 001-38266 23780865 34 227788 1 1
2023-03-30 10-K 10-K 0000950170-23-010921 001-38266 23780576 34 17421048 1 1
2023-02-14 SC 13G/A AMENDMENT NO. 5 TO THE SCHEDULE 13G 0000921895-23-000526 005-90168 23625002 34 266352
2023-02-14 SC 13G/A spro_13gv5.htm 0001591986-23-000003 005-90168 23624644 34 80352
2023-02-06 4 FORM 4 SUBMISSION 0000899243-23-004039 5381
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003948 7158
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003946 7077
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003945 7449
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003942 5182
2023-02-03 4 FORM 4 SUBMISSION 0000899243-23-003939 5374
2023-02-01 8-K 8-K 5.02 0001193125-23-021612 001-38266 23577183 34 152830 1 1
2023-01-20 SC 13D/A SCHEDULE 13D/A 0001387131-23-000462 005-90168 23541035 34 41895
2023-01-19 CT ORDER filename1.pdf 20230119,20230119 9999999997-23-000264 001-38266 23536921 34 160856
2023-01-09 8-K 8-K 2.02,7.01,8.01,9.01 0001193125-23-004190 001-38266 23516698 34 15874738 1 1
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000990 5856
2023-01-05 4 FORM 4 SUBMISSION 0000899243-23-000983 5801
2022-11-15 D xslFormDX01/primary_doc.xml 06b 0001701108-22-000001 021-464777 221388160 33 15459
2022-11-14 3 xslF345X02/ownership.xml 0001387131-22-011408 4386
2022-11-14 SC 13D/A SCHEDULE 13D/A 0001387131-22-011406 005-90168 221387276 34 94495
2022-11-14 S-8 S-8 0001193125-22-284615 333-268344 221385759 33 77083
2022-11-14 8-K 8-K 2.02,9.01 0001193125-22-284579 001-38266 221385466 34 235458 1 1
2022-11-14 10-Q 10-Q 0000950170-22-024971 001-38266 221385016 34 15173946 1 1
2022-11-08 8-K 8-K 8.01,9.01 0001193125-22-279724 001-38266 221367342 34 165874 1 1
2022-10-03 SC 13G/A 13G_sprov4.htm 0001591986-22-000019 005-90168 221287996 34 110307
2022-09-26 4 PRIMARY DOCUMENT 0001591986-22-000018 9999
2022-09-22 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-22-248772 001-38266 221257867 34 209718 1 1
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031505 4958
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031504 4980
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031503 4986
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031502 4942
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031498 4986
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031497 5010
2022-09-19 4 FORM 4 SUBMISSION 0000899243-22-031495 4955
2022-09-19 8-K 8-K 5.02,5.07,9.01 0001193125-22-247168 001-38266 221251299 34 299008 1 1
2022-09-14 4 FORM 4 SUBMISSION 0000899243-22-031094 5054
2022-09-14 3 FORM 3 SUBMISSION 0000899243-22-031091 6880
2022-09-06 8-K 8-K 8.01,9.01 0001193125-22-238439 001-38266 221226940 34 167733 1 1
2022-08-30 4 FORM 4 SUBMISSION 0000899243-22-030087 5890
2022-08-10 8-K 8-K 2.02,9.01 0001193125-22-217351 001-38266 221151895 34 226239 1 1
2022-08-10 10-Q 10-Q 0000950170-22-016443 001-38266 221151762 34 12308069 1 1
2022-08-05 DEFA14A DEFA14A 0001193125-22-213590 001-38266 221140843 34 784988
2022-08-05 DEF 14A DEF 14A 0001193125-22-213583 001-38266 221140774 34 1014670
2022-07-08 SC 13G us84833t1034_070822.txt 0000834237-22-010269 005-90168 221075029 34 12321
2022-07-01 8-K 8-K 5.02 0001193125-22-187190 001-38266 221061411 34 150313 1 1
2022-06-27 8-K 8-K 8.01,9.01 0001193125-22-182828 001-38266 221044662 34 167650 1 1
2022-06-07 8-K 8-K 1.02,9.01 0001193125-22-169252 001-38266 221001220 34 188492 1 1
2022-05-16 8-K 8-K 2.02,9.01 0001193125-22-151708 001-38266 22929024 34 216548 1 1
2022-05-16 10-Q 10-Q 0000950170-22-010064 001-38266 22928628 34 10248090 1 1
2022-05-03 8-K 8-K 2.05,5.02,8.01,9.01 0001193125-22-137586 001-38266 22884576 34 198380 1 1
2022-04-28 4 PRIMARY DOCUMENT 0001591986-22-000015 8000
2022-04-07 8-K 8-K 8.01,9.01 0001193125-22-097712 001-38266 22811555 34 168211 1 1
2022-03-31 8-K 8-K 2.02,9.01 0001193125-22-091793 001-38266 22792733 34 235727 1 1
2022-03-31 10-K 10-K 0000950170-22-005194 001-38266 22792316 34 16531884 1 1
2022-03-31 4 PRIMARY DOCUMENT 0001591986-22-000014 10008
2022-03-16 4 PRIMARY DOCUMENT 0001591986-22-000013 10005
2022-03-09 SC 13G/A 13G_sprov3.htm 0001591986-22-000012 005-90168 22722941 34 109835
2022-03-02 4 PRIMARY DOCUMENT 0001591986-22-000011 9986
2022-02-23 4 PRIMARY DOCUMENT 0001591986-22-000010 7979
2022-02-16 8-K 8-K 8.01,9.01 0001193125-22-044007 001-38266 22641557 34 169814 1 1
2022-02-14 SC 13G/A spro_13gv1.htm 0001591986-22-000008 005-90168 22630941 34 77815
2022-02-14 SC 13G/A AMENDMENT NO. 4 TO THE SCHEDULE 13G 0000921895-22-000525 005-90168 22628819 34 286896
2022-02-03 SC 13G/A us84833t1034_020322.txt 0000834237-22-006197 005-90168 22588786 34 13284
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004594 11636
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004593 11606
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004592 11665
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004591 7864
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004589 11667
2022-02-03 4 FORM 4 SUBMISSION 0000899243-22-004586 11537
2022-02-01 4 PRIMARY DOCUMENT 0001591986-22-000004 8016
2022-01-26 4 PRIMARY DOCUMENT 0001591986-22-000003 8012
2022-01-25 SC 13G/A SCHEDULE 13G/A 0001104659-22-007249 005-90168 22551870 34 78806
2022-01-25 8-K 8-K 7.01,8.01,9.01 0001193125-22-016568 001-38266 22551176 34 13880759 1 1
2022-01-20 4 PRIMARY DOCUMENT 0001591986-22-000002 8014
2022-01-19 8-K 8-K 8.01,9.01 0001193125-22-011967 001-38266 22536820 34 166724 1 1
2022-01-12 4 PRIMARY DOCUMENT 0001591986-22-000001 8012
2022-01-07 4 FORM 4 SUBMISSION 0000899243-22-001380 5854
2022-01-07 4 FORM 4 SUBMISSION 0000899243-22-001378 9655
2022-01-07 4 FORM 4 SUBMISSION 0000899243-22-001376 9592
2022-01-04 8-K 8-K 8.01,9.01 0001193125-22-001112 001-38266 22504142 34 183587 1 1
2022-01-03 4 PRIMARY DOCUMENT 0001691902-22-000001 12032
2021-12-29 4 FORM 4 SUBMISSION 0000899243-21-050049 14188
2021-12-16 CT ORDER filename1.pdf 20211216,20211216 9999999997-21-005992 001-38266 211497626 34 122568
2021-11-12 4 FORM 4 SUBMISSION 0000899243-21-044352 5603
2021-11-10 8-K 8-K 2.02,9.01 0001193125-21-326025 001-38266 211396926 34 221100 1 1
2021-11-10 10-Q 10-Q 0000950170-21-004064 001-38266 211396451 34 11392418 1 1
2021-11-02 4 PRIMARY DOCUMENT 0001591986-21-000016 8018
2021-10-28 8-K 8-K 7.01,8.01,9.01 0001193125-21-310428 001-38266 211355148 34 166681 1 1
2021-10-14 3 FORM 3 SUBMISSION 0000899243-21-040250 6913
2021-10-12 8-K 8-K 5.02,9.01 0001193125-21-296407 001-38266 211316980 34 172768 1 1
2021-10-04 4 PRIMARY DOCUMENT 0001591986-21-000015 8018
2021-09-30 8-K 8-K 1.01,2.03,9.01 0001193125-21-287391 001-38266 211293682 34 1119731 1 1
2021-09-20 S-8 S-8 0001193125-21-277265 333-259662 211263252 33 131708
2021-09-16 SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-21-009489 005-90168 211258717 34 62658
2021-09-15 4 PRIMARY DOCUMENT 0001591986-21-000014 10023
2021-09-10 4 PRIMARY DOCUMENT 0001591986-21-000013 8016
2021-09-01 4 PRIMARY DOCUMENT 0001591986-21-000012 10025
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034503 5110
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034502 5308
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034501 5111
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034500 5069
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034499 5113
2021-08-30 4 FORM 4 SUBMISSION 0000899243-21-034498 5096
2021-08-30 8-K 8-K 5.02,9.01 0001193125-21-260572 001-38266 211223526 34 197628 1 1
2021-08-27 4 PRIMARY DOCUMENT 0001591986-21-000011 10024
2021-08-24 4 PRIMARY DOCUMENT 0001591986-21-000010 12036
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033479 5517
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033477 5473
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033469 5511
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033468 5517
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033463 5486
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033460 5489
2021-08-18 8-K 8-K 5.02,5.03,5.07,9.01 0001193125-21-250505 001-38266 211187207 34 320890 1 1
2021-08-18 4 FORM 4 SUBMISSION 0000899243-21-033456 6131
2021-08-05 8-K 8-K 2.02,9.01 0001193125-21-237754 001-38266 211148576 34 218374 1 1
2021-08-05 10-Q 10-Q 0000950170-21-000924 001-38266 211148069 34 11291496 1 1
2021-07-14 D xslFormDX01/primary_doc.xml 06b 0001701108-21-000001 021-406258 211090286 33 16323
2021-07-09 SC 13G SC 13G SPERO THERAPEUTICS, INC. 0000078003-21-000085 005-90168 211083071 34 40365
2021-07-06 DEF 14A DEF 14A 0001193125-21-208448 001-38266 211073276 34 1632995
2021-07-01 8-K 8-K 1.01,3.02,9.01 0001193125-21-205054 001-38266 211063435 34 181986 1 1
2021-06-25 PRE 14A PRE 14A 0001193125-21-200402 001-38266 211048169 34 1631865
2021-05-06 8-K 8-K 2.02,9.01 0001193125-21-153274 001-38266 21897813 34 206127 1 1
2021-05-06 10-Q 10-Q Q1 2021 0001564590-21-024932 001-38266 21897597 34 8523529 1 1
2021-03-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-03-29 16:00:00 9999999995-21-001188 333-254170 21783481 33 1827
2021-03-24 CORRESP filename1.htm 0001193125-21-092583 10631
2021-03-23 10-K/A 10-K/A 0001193125-21-091148 001-38266 21764785 34 396124
2021-03-17 UPLOAD filename1.pdf 0000000000-21-003234 40363
2021-03-11 S-8 S-8 0001193125-21-077939 333-254173 21734082 33 64038
2021-03-11 S-3 S-3 0001193125-21-077926 333-254170 21734024 33 1279354
2021-03-11 8-K 8-K 2.02,9.01 0001193125-21-077864 001-38266 21733743 34 218442 1 1
2021-03-11 10-K 10-K 0001564590-21-012514 001-38266 21733442 34 15253551 1 1
2021-02-16 SC 13D/A AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP 0001839882-21-002172 005-90168 21641167 34 70501
2021-02-16 SC 13G/A spro_13g.htm 0001591986-21-000004 005-90168 21637697 34 78423
2021-02-16 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-21-000405 005-90168 21631329 34 295657
2021-02-10 SC 13G/A SC 13G/A 0001193125-21-036356 005-90168 21614429 34 119688
2021-02-10 4 PRIMARY DOCUMENT 0001591986-21-000003 7695
2021-02-05 8-K 8-K 8.01,9.01 0001193125-21-029880 001-38266 21593761 34 172569 1 1
2021-02-04 4 PRIMARY DOCUMENT 0001591986-21-000001 12779
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004790 5599
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004786 5597
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004783 5623
2021-02-03 4 FORM 4 SUBMISSION 0000899243-21-004782 5596
2021-02-02 SC 13G us84833t1034_020221.txt 0000834237-21-007121 005-90168 21580873 34 13266
2021-02-02 SC 13G/A SC 13G/A 0001104659-21-010772 005-90168 21580009 34 121753
2021-01-19 8-K 8-K 1.01 0001193125-21-010857 001-38266 21533973 34 152597 1 1
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000695 5764
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000692 5751
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000691 5795
2021-01-06 4 FORM 4 SUBMISSION 0000899243-21-000690 5789
2021-01-05 4 FORM 4 SUBMISSION 0000899243-21-000366 5582
2021-01-05 3 FORM 3 SUBMISSION 0000899243-21-000360 7179
2020-12-18 4 PRIMARY DOCUMENT 0001591986-20-000019 9393
2020-12-18 4 FORM 4 SUBMISSION 0000899243-20-034477 8879
2020-12-17 8-K 8-K 5.02,8.01,9.01 0001193125-20-319592 001-38266 201394264 34 181220 1 1
2020-12-07 SC 13D/A AMENDMENT NO. 5 TO SC 13D 0001387131-20-010519 005-90168 201373400 34 92964
2020-12-03 8-K 8-K 7.01,8.01,9.01 0001193125-20-308948 001-38266 201365697 34 17451173 1 1
2020-12-02 4 FORM 4 SUBMISSION 0000899243-20-032557 5554
2020-12-02 3 FORM 3 SUBMISSION 0000899243-20-032553 7233
2020-11-13 424B5 424B5 0001193125-20-292384 333-228661 201309285 33 211008
2020-11-10 4 PRIMARY DOCUMENT 0001591986-20-000016 7699
2020-11-06 4 PRIMARY DOCUMENT 0001591986-20-000015 11084
2020-11-05 4 FORM 4 SUBMISSION 0000899243-20-030490 15884
2020-11-05 8-K 8-K 2.02,9.01 0001193125-20-286841 001-38266 201290682 34 218789 1 1
2020-11-05 10-Q 10-Q 0001564590-20-051279 001-38266 201290319 34 11756621 1 1
2020-10-28 8-K 8-K 5.07 0001193125-20-279790 001-38266 201268674 34 157039 1 1
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029338 6087
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029337 5473
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029334 5429
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029333 5445
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029329 5467
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029328 9435
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029327 5442
2020-10-27 4 FORM 4 SUBMISSION 0000899243-20-029326 5473
2020-10-15 4 FORM 4 SUBMISSION 0000899243-20-028430 15355
2020-09-30 DEF 14A DEF 14A 0001193125-20-259653 001-38266 201212502 34 1088938
2020-09-23 SC 13G/A spro_13g_v2.htm 0001591986-20-000014 005-90168 201190557 34 78349
2020-09-22 3 PRIMARY DOCUMENT 0001591986-20-000013 6688
2020-09-16 8-K 8-K 7.01,9.01 0001193125-20-246775 001-38266 201177461 34 16312815 1 1
2020-09-14 8-K 8-K 1.01,5.03,8.01,9.01 0001193125-20-244804 001-38266 201172442 34 651812 1 1
2020-09-14 424B5 424B5 0001193125-20-244773 333-228661 201172393 33 526424
2020-09-10 4 FORM 4 SUBMISSION 0000899243-20-024865 9970
2020-09-09 424B5 424B5 0001193125-20-242277 333-228661 201167117 33 530237
2020-09-09 8-K 8-K 8.01 0001193125-20-242243 001-38266 201166944 34 149602 1 1
2020-09-08 8-K 8-K 7.01,8.01,9.01 0001193125-20-240546 001-38266 201162970 34 7616335 1 1
2020-08-06 S-8 S-8 0001193125-20-211997 333-241681 201082414 33 59116
2020-08-06 8-K 8-K 2.02,9.01 0001193125-20-211931 001-38266 201082011 34 215627 1 1
2020-08-06 10-Q 10-Q 0001564590-20-037710 001-38266 201081480 34 11582367 1 1
2020-07-09 4 FORM 4 SUBMISSION 0000899243-20-018847 15881
2020-06-29 4 FORM 4 SUBMISSION 0001209191-20-039352 25595
2020-06-23 4 FORM 4 SUBMISSION 0000899243-20-017496 5510
2020-06-04 SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-20-005474 005-90168 20943604 34 93535
2020-06-04 8-K 8-K 7.01,8.01,9.01 0001193125-20-160206 001-38266 20941989 34 15613725
2020-05-11 8-K/A 8-K/A 5.02 0001193125-20-139200 001-38266 20865719 34 15756
2020-05-08 8-K 8-K 2.02,9.01 0001193125-20-137009 001-38266 20858792 34 61167
2020-05-08 10-Q 10-Q 0001564590-20-023243 001-38266 20858703 34 8456643 1
2020-04-23 3 FORM 3 SUBMISSION 0000899243-20-011244 7060
2020-04-16 8-K 8-K 5.02,9.01 0001193125-20-108749 001-38266 20795276 34 44722
2020-03-19 S-8 S-8 0001193125-20-079102 333-237283 20728936 33 59911
2020-03-16 8-K 8-K 2.02,9.01 0001193125-20-073981 001-38266 20715452 34 67696
2020-03-16 10-K 10-K 0001564590-20-010998 001-38266 20715376 34 12296217 1
2020-02-28 8-K 8-K 3.03,5.03,8.01,9.01 0001193125-20-056529 001-38266 20670861 34 126685
2020-02-18 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0001193805-20-000223 005-90168 20622903 34 306190
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D 0001387131-20-001836 005-90168 20621085 34 54222
2020-02-14 SC 13G/A spro_13gv5.htm 0001591986-20-000005 005-90168 20613115 34 78263
2020-02-11 8-K 8-K 2.02,8.01,9.01 0001193125-20-030705 001-38266 20594099 34 224159
2020-02-11 424B5 424B5 0001193125-20-030568 333-228661 20593862 33 603728
2020-02-04 SC 13G/A SCHEDULE 13G/A 0001104659-20-010526 005-90168 20573095 34 90084
2020-02-03 4 FORM 4 SUBMISSION 0000899243-20-002618 5595
2020-02-03 4 FORM 4 SUBMISSION 0000899243-20-002617 5591
2020-02-03 4 FORM 4 SUBMISSION 0000899243-20-002616 5596
2020-02-03 4 FORM 4 SUBMISSION 0000899243-20-002604 5598
2020-01-31 SC 13G/A SC 13G/A 0001193125-20-021361 005-90168 20565337 34 75065
2020-01-30 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-20-019086 001-38266 20559799 34 187219
2020-01-13 3 FORM 3 SUBMISSION 0000899243-20-001061 15994
2020-01-06 4 FORM 4 SUBMISSION 0000899243-20-000631 5786
2020-01-06 4 FORM 4 SUBMISSION 0000899243-20-000629 6298
2020-01-06 4 FORM 4 SUBMISSION 0000899243-20-000628 5798
2020-01-06 4 FORM 4 SUBMISSION 0000899243-20-000625 5787
2019-12-19 8-K 8-K 1.01,2.03,9.01 0001193125-19-319256 001-38266 191296454 34 77118
2019-12-05 8-K 8-K 7.01,9.01 0001193125-19-306821 001-38266 191269513 34 17121131
2019-11-08 3 FORM 3 SUBMISSION 0000899243-19-026993 7025
2019-11-04 8-K 8-K 2.02,9.01 0001193125-19-283355 001-38266 191189935 34 63923
2019-11-04 10-Q 10-Q 0001564590-19-039770 001-38266 191189711 34 9877720 1
2019-10-03 8-K 8-K 7.01,9.01 0001193125-19-261358 001-38266 191134947 34 28423
2019-09-06 8-K 8-K 5.02 0001193125-19-239450 001-38266 191078522 34 18400
2019-08-08 8-K 8-K 2.02,9.01 0001193125-19-216834 001-38266 191009600 34 65882
2019-08-08 10-Q 10-Q 0001564590-19-030746 001-38266 191009399 34 9659321 1
2019-06-14 424B5 424B5 0001193125-19-172777 333-228661 19897460 33 402264
2019-06-13 8-K 8-K 1.01,9.01 0001193125-19-171876 001-38266 19894936 34 138833
2019-06-06 8-K 8-K 5.07 0001193125-19-167255 001-38266 19883026 34 22159
2019-06-05 4 FORM 4 SUBMISSION 0000899243-19-015673 5424
2019-06-05 4 FORM 4 SUBMISSION 0000899243-19-015672 5468
2019-06-05 4 FORM 4 SUBMISSION 0000899243-19-015668 5461
2019-06-05 4 FORM 4 SUBMISSION 0000899243-19-015667 6107
2019-06-05 4 FORM 4 SUBMISSION 0000899243-19-015665 5462
2019-06-05 4 FORM 4 SUBMISSION 0000899243-19-015663 5437
2019-05-09 8-K 8-K 2.02,9.01 0001193125-19-142982 001-38266 19810633 34 57699
2019-05-09 10-Q 10-Q 0001564590-19-017941 001-38266 19810375 34 8181705 1
2019-04-26 DEF 14A DEF 14A 0001193125-19-122422 001-38266 19772055 34 734422
2019-04-18 8-K 8-K 5.02 0001193125-19-111025 001-38266 19756538 34 16082

Latest XBRL company facts

One latest value per concept from companyfacts (305 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 58.26M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
dei EntityPublicFloat Entity Public Float USD 160.30M 2025-06-30 2025 FY 10-K 2026-03-26 0001193125-26-126192
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.27M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182201
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.44M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182201
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 12 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182201
ffd NetFeeAmt NetFeeAmt USD 184.92 2026-10-27 S-8 2026-10-28 0001193125-26-436376
ffd TtlFeeAmt TtlFeeAmt USD 184.92 2026-10-27 S-8 2026-10-28 0001193125-26-436376
ffd TtlOfferingAmt TtlOfferingAmt USD 2.13M 2026-10-27 S-8 2026-10-28 0001193125-26-436376
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-27 S-8 2026-10-28 0001193125-26-436376
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-28 S-3 2026-08-28 0001193125-26-374702
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 411,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 830,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 48.41M 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005194
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.62M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 267.08M 2019-09-30 2019 Q3 10-Q 2019-11-04 0001564590-19-039770
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 512.82M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 100,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 8.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap Assets Assets USD 110.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AssetsCurrent Assets, Current USD 109.23M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 2,000 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 33.82M 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 90.75M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028526
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028526
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 25,000 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028526
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 90.77M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028526
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 33.82M 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap BusinessCombinationIntegrationRelatedCosts Business Combination, Integration Related Costs USD 8.60M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 75,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023243
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 107.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 700,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -34.79M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012933
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 52.55M 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012933
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 107.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 67.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007402
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 8.45M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 240.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 58.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 58.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap CommonStockValue Common Stock, Value, Issued USD 58,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 22.81M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 8.06M 2017-09-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051279
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 229,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 833,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap DeferredRevenue Deferred Revenue USD 10.44M 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024971
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 119.42M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 388,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 60.31M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 236.50M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 4.70M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 218.90M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 184.80M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 73.00M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 3.40M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 11.15M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 119.03M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 388,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 11.61M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 153,000 2018-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap DerivativeLiabilities Derivative Liability USD 54.50M 2022-06-07 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 141,000 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024971
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024971
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.01 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.344 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.238 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005194
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0.01 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.135 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingenciesOther Effective Income Tax Rate Reconciliation, Tax Contingency, Other, Percent pure -0.01 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.054 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet Embedded Derivative, Gain (Loss) on Embedded Derivative, Net USD 100,000 2022-06-01 2022-06-30 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 800,000 2016-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007402
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap FairValueDisclosureOffbalanceSheetRisksAmountAsset Fair Value Disclosure, Off-balance Sheet Risks, Amount, Asset USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -184,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012514
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 600,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024971
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD 8.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 8.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -78.28M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012514
us-gaap IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net USD 8.83M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxesPaid Income Taxes Paid USD 99,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -2.21M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062897
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -3.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 1.85M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 12,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 480,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -282,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -220,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInCustomerAdvancesAndDeposits Increase (Decrease) in Customer Advances and Deposits USD -929,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD -53,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInOtherDeferredLiability Increase (Decrease) in Other Deferred Liability USD 554,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -91,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -153,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -346,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 30,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007402
us-gaap InterestExpenseOther Interest Expense, Other USD 3.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 1.39M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-04 0001564590-19-039770
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap LeaseCost Lease, Cost USD 1.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.11M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.16M 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005194
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.96M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.16M 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.96M 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.16M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.16M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 382,000 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051279
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 217,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap Liabilities Liabilities USD 109.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 110.03M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap LiabilitiesCurrent Liabilities, Current USD 56.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap LiabilitiesSubjectToCompromiseEarlyContractTerminationFees Liabilities Subject to Compromise, Early Contract Termination Fees USD 3.00M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap MinorityInterest Stockholders' Equity Attributable to Noncontrolling Interest USD 355,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 99.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 43.00M 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012933
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -22.82M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012933
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -32.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -11.96M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012933
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -61.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD -1.14M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -47.68M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0000950170-24-127016
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OperatingExpenses Operating Expenses USD 59.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -59.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 900,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-05 0001564590-20-051279
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 635,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-14 0000950170-22-024971
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.90M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.75M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 798,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 7.89M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.36M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.12M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.11M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 995,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.05M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 2.25M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 248,000 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028526
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 800,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.098 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 226.10M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherAssetsCurrent Other Assets, Current USD 12,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherCommitment Other Commitment USD 105.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD -6,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012514
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap OtherLongTermDebtNoncurrent Other Long-term Debt, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap OtherReceivables Other Receivables USD 44,000 2026-03-31 2026 Q1 10-Q 2026-05-13 0001193125-26-221591
us-gaap OtherRestructuringCosts Other Restructuring Costs USD 3.08M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 2.60M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap PaymentsForProceedsFromOtherInvestingActivities Payments for (Proceeds from) Other Investing Activities USD 0 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041314
us-gaap PaymentsForRestructuring Payments for Restructuring USD 714,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap PaymentsOfDerivativeIssuanceCosts Payments of Derivative Issuance Costs USD 908,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004064
us-gaap PaymentsToMinorityShareholders Payments to Noncontrolling Interests USD 1.18M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007402
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005194
us-gaap PreferredStockDividendsPerShareCashPaid Preferred Stock, Dividends, Per Share, Cash Paid USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007402
us-gaap PreferredStockDividendsPerShareDeclared Preferred Stock, Dividends Per Share, Declared USD/shares 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-02 0001564590-18-007402
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 77.75M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap ProceedsFromRoyaltiesReceived Proceeds from Royalties Received USD 50.00M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -61.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 3.62M 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap PropertyPlantAndEquipmentSalvageValuePercentage Property, Plant and Equipment, Salvage Value, Percentage pure 0.75 2022-05-03 2022 Q2 10-Q 2022-08-10 0000950170-22-016443
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 1,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012514
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 6.15M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 10.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010921
us-gaap ResearchAndDevelopmentArrangementWithFederalGovernmentCostsIncurredNet Research and Development Arrangement with Federal Government, Costs Incurred, Net USD 6.90M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 9.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 50,000 2017-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap RestructuringCharges Restructuring Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap RestructuringCosts Restructuring Costs USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap RestructuringReserve Restructuring Reserve USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 39,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -512.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 1.15M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012933
us-gaap Revenues Revenues USD 258,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap RoyaltyGuaranteesCommitmentsAmount Royalty Guarantees, Commitments, Amount USD 1.00M 2021-12-31 2022 Q3 10-Q 2022-11-14 0000950170-22-024971
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap SeparateAccountLiabilityPremium SeparateAccountLiabilityPremium USD 12.50M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004064
us-gaap SeveranceCosts1 Severance Costs USD 258,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.747 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.029 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 402,857 2017-06-01 2017-06-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 250,000 2023-07-01 2023-07-31 2023 Q3 10-Q 2023-11-13 0000950170-23-062897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 23.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 2.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 9.89 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 91,925 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 11.75 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 91,925 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.29 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-13 0000950170-23-062897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 21,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.6 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 3.96M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 21,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 6.6 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-31 0000950170-22-005194
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070380
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.97 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 5.9 2017-07-29 2017-07-31 2019 FY 10-K 2020-03-16 0001564590-20-010998
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.001 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap SharesOutstanding Shares, Outstanding shares 3.22M 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004064
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 781,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 132.04M 2020-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012514
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 1 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-10 0000950170-23-041314
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-13 0000950170-25-070380
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 2,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 221,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-27 0000950170-25-046125
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 420,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-13 0000950170-24-030767
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 21,116 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-14 0001564590-19-007805
us-gaap SubleaseIncome Sublease Income USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap TaxCreditCarryforwardAmount Tax Credit Carryforward, Amount USD 3.10M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense USD 9.40M 2017-01-01 2017-12-31 2020 FY 10-K 2021-03-11 0001564590-21-012514
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 163,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests USD 106.11M 2017-09-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 108.37M 2017-09-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 43.30M 2017-09-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 43.26M 2017-09-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 43.26M 2017-09-30 2017 Q3 10-Q 2017-12-14 0001193125-17-369457
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 3.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126192
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 57.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 32.61M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-16 0000950170-22-010064
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 57.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458593

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →